Prevalence of Iron Deficiency in acute heart Failure

Prevalence of Iron Deficiency in acute heart Failure - Prevalence study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON50256

Enrollment

1000

Registered

2017-03-09

Start date

2017-06-26

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Failure of te heart function Heart failure

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Hospitalisation due to acute heart failure

Exclusion criteria

Exclusion criteria: - History of erythropoietin stimulating agent, IV iron therapy, and/or blood transfusion in previous 3 months prior to hospitalisation. - Oral iron therapy at any dose and/or continious use of iron containing multivitamines in previous 4 weeks prior to hospitalisation. - History of receiving systemic chemotherapy and/or radiotherapy in previous 3 months prior to hospitalisation.

Design outcomes

Primary

Measure	Time frame
Prevalence of iron deficiency according to the definition of the ESC guidelines	—

Secondary

Measure	Time frame
- Associations between type and measures of severity of heart failure and iron deficiency; - Time course of measures of iron (deficiency), heart failure and co-morbidities	—

Countries

Netherlands

Outcome results